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Abstract 
Versican, a large chondroitin sulfate proteoglycan, plays a role in conditions such as wound healing 
and tissue remodeling.   To test the hypothesis that versican is transiently expressed and plays a 
role in the infarcted heart, we examined its expression in a rat model of myocardial infarction.  
Northern blot analysis demonstrated increased expression of versican mRNA.  Quantitative 
real-time RT-PCR analysis revealed that versican mRNA began to increase as early as 6 hours and 
reached its maximal level 2 days after coronary artery ligation.  Versican mRNA then gradually 
decreased, while the mRNA of decorin, another small proteoglycan, increased thereafter.  
Versican mRNA was localized in monocytes, as indicated by CD68-positive staining, around the 
infarct tissue.   The induction of versican mRNA was accelerated by ischemia/reperfusion (I/R), 
which was characterized by massive cell infiltration and enhanced inflammatory response. To 
examine the alteration of versican expression in monocytes/macrophages, we isolated human 
peripheral blood mononuclear cells and stimulated them with granulocyte/macrophage 
colony-stimulating factor (GM-CSF).  Stimulation of mononuclear cells with GM-CSF increased 
the expression of versican mRNA as well as cytokine induction.  The production of versican by 
monocytes in the infarct area represents a novel finding of the expression of an extracellular matrix 
gene by monocytes in the infarcted heart. We suggest that upregulation of versican in the infarcted 
myocardium may have a role in the inflammatory reaction, which mediates subsequent chemotaxis 
in the infarcted heart. 
 
Key Words: coronary artery disease, cytokine, extracellular matrix, GM-CSF, monocyte 
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Introduction:  
The extracellular matrix (ECM) has recently been recognized not only to play a part in 
contributing to the shape and biomechanical strength of organs and tissues, but also to function in 
the modulation of cell-matrix interactions resulting in cell-signaling [1].   During the healing of 
the infarcted heart, the sequential changes that occur in the infarct area in the myocardium initially 
involve the processes of cell infiltration and chemotaxis, which then affect subsequent ventricular 
remodeling [2].  During inflammation, activated monocytes migrate into tissues, where they 
interact with extracellular matrix components, such as hyaluronan (HA), produced in high amounts 
at inflammatory sites.  During inflammatory immune responses, HA as well as HA-related 
molecules are thought to have roles in monocyte attachment.  
Versican is a member of the chondroitin sulfate proteoglycan (CSPG) family, also referred 
to as the hyalectan family because of the capacity of these molecules to bind to HA. Hyalectans 
consist of versican, aggrecan, neurocan, and brevican [3].   Although aggrecan is most abundant 
in cartilage, while both neurocan and brevican are restricted to nerve tissues, versican is rather 
widely distributed in tissues, including the heart [4-5].   Versican has roles in modulating cell-cell 
and cell-matrix interactions during cell migration and proliferation processes [6].   Furthermore, 
the accumulation of a versican- and HA-enriched ECM has been suggested to have a role in 
inflammation [7].   For example, HA can serve as an attachment ligand for macrophages [8] and 
lymphocytes through CD44-mediated interactions [9].  Accordingly, we hypothesized that 
versican is involved in the inflammatory reaction after myocardial infarction (MI).   
Granulocyte/macrophage colony-stimulating factor (GM-CSF) is a cytokine that stimulates 
the growth and differentiation of granulocyte and macrophage precursor cells in vitro [10].  
Recently, GM-CSF was reported to facilitate infarct expansion in association with the promotion of 
monocyte recruitment [11].   However, the molecular mechanism by which this cytokine affects 
the infarcted heart is not fully understood.  Thus, we examined the effect of GM-CSF on versican 
mRNA expression in human peripheral blood mononuclear cell (PBMC) cultures.  
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MATERIALS AND METHODS 
Experimental myocardial infarction  
All protocols involving experimental animals followed our local institutional guidelines for 
animal care, which are comparable to the “Guide for the Care and Use of Laboratory Animals” 
published by the Institute for Laboratory Animal Research (National Institutes of Health 
publication No. 85-23, revised 1996).   The method for induction of MI has been reported by our 
group [12-17].  Adult Sprague-Dawley male rats weighing 200 to 250 g were anesthetized with 
sodium pentobarbital (50 mg/kg, intraperitoneally) and the left coronary artery was ligated 
permanently.   Echocardiographic studies were performed before the surgical procedure and 
immediately before sacrificing animals, as previously described [18]. LV wall motion asynergy 
due to MI was confirmed using ultrasound sonography (ProSound SSD- 4000; Aloka CO., LTD., 
Tokyo, Japan).  Rats were allowed to recover and then killed at each indicated time as described 
below.  In each analysis, sham-operated rats were also killed on the schedule noted below to serve 
as a control group. All tissues were weighed and rapidly frozen in liquid nitrogen and stored at 
-70°C. For RT-PCR analysis, pats were sacrificed at 3 hours, 6 hours, 12 hours, 1 day, 2 days, 7 
days, 14 days, or 28 days post-MI and sham-operated rats served as controls (n=6 at each time 
point).  In vivo ischemia and reperfusion (I/R) was induced as we previously described [2-19].  
Briefly, reperfusion was carried out after 45 min of coronary ligation and it was confirmed by 
observation of hyperemic color of the ischemic myocardium (n=4).  Rats were sacrificed at 2 days 
after coronary ligation or I/R for quantitative RT-PCR analysis.  For the in situ hybridization and 
immunohistochemical staining, 3 rats were sacrificed 2 days after coronary obstruction.   
Splicing variant analysis 
The primers used in the initial semi-quantitative RT-PCR reaction were designed according 
to our previous report (Table I) [20].   Splicing variant-specific primers were designed using the 
sequence of mouse versican.   Rat brain cDNA and nuclease-free water were used for positive- 
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and negative-controls, respectively.   The number of PCR cycles was determined as previously 
reported [21].  Briefly, PCR was performed for 20 cycles, and the numbers of cycles was then 
increased by 2 cycles up to 30.  Densities of the bands of PCR products were compared on the 
same agarose gel after electrophoresis and the number of cycles was determined as the number that 
showed a linear trajectory before it reached the maximum plateau. 
Northern blotting 
Northern blot analysis was performed following the protocol previously reported [22].  
Aliquots of total RNA (40 μg from each tissue) were electrophoresed on 1% agarose-formaldehyde 
gels and then transferred to nylon membranes.   The probe for versican cDNA used for Northern 
blotting was the same as recently reported [23].  The membranes were hybridized with 
α32P-labelled cDNA probes at 65 °C for 3 hr.    After the radiolabelled filters were washed under 
stringent conditions, they were exposed to an imaging plate (Fuji Photo Film Inc., Tokyo, Japan), 
which was developed using an image analysis system (BAS-2000, Fuji Photo Film Inc.).  The 28S 
ribosomal RNA (rRNA) bands stained with ethidium bromide served as an internal control for 
comparison. 
Quantitative RT-PCR analysis 
To examine the changes in the level of versican mRNA in more detail, samples were 
analyzed by quantitative real-time RT-PCR as previously described [17].  The primers used for 
quantitative RT-PCR were designed in the α-domain of versican, and thus detected the net level of 
the expression of V0 and V1 mRNAs (Table I).  Briefly, quantification of the mRNAs coding for 
versican, decorin and GAPDH was performed using the LightCycler rapid thermal cycler system 
(Roche Diagnostics Ltd, Lewes, UK) according to the manufacturer's instructions.   A typical 
protocol took approximately 45 min to complete and included a 10-min denaturation step followed 
by 40 cycles of a 95 °C denaturation for 10 seconds, 65 °C annealing for 5 seconds, and 72 °C 
extension for 20 seconds.   There was rarely significant primer dimer formation within the 
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number of cycles required for quantification for a range of experimental samples.   Each RT-PCR 
was repeated at least 3 times to ascertain reproducibility, and data were analyzed using the absolute 
standard curve method [17].   The scores of “relative versican”, which indicated the expression of 
versican relative to that of GAPDH, were obtained by dividing the number of copies of versican 
transcript in a sample by the corresponding correction factor as previously described [17].   
In situ hybridization 
In situ hybridization was performed as previously reported [24].   The hearts were fixed 
with 4 % paraformaldehyde.  The specimens were then cut and placed on silane-coated glass 
slides (DakoCytomation, Kyoto, Japan).  Probes were synthesized by RT-PCR by using 
gene-specific primers, which were identical to those used for real-time RT-PCR analysis, and 
ligated into TA cloning vector.  Digoxigenin-UTP-labelled sense and antisense cRNA probes were 
synthesized by in vitro transcription with the relevant RNA polymerases.  Hybridization was 
carried out overnight at 42 °C in a humidified chamber with digoxigenin-UTP-labelled antisense or 
sense probe.  Immunological detection of digoxigenin-labelled transcripts was performed 
according to the manufacturer's protocol (Boehringer-Mannheim).   Finally, the sections were 
lightly counterstained with nuclear fast red (Merck, Darmstadt, Germany).    
Immunohistochemistry 
Immunohistochemical analysis was performed as previously reported [12-25].   Briefly, 
rat hearts were fixed with 10% buffered formalin and embedded in paraffin, and then cut 
into 5 to 6-μm sections and placed on silane-coated glass slides (DakoCytomation, Kyoto, 
Japan).  Monoclonal antibody against human CD68 was purchased from Serotec Ltd (Oxford, 
UK).  After the sections were washed with PBS with 0.01% Triton X-100, they were treated with 
the second antibody (peroxidase-conjugated goat anti-mouse IgG (Nichirei, Tokyo, Japan) was 
used as the secondary antibody for CD68) for 60 min at room temperature.  Finally, the sections 
were washed 3 times in PBS with 0.01 % Triton X-100 for 5 min each time.  The sections were 
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then treated using an AEC kit (DAKO, Carpinteria, CA, USA).  All other chemicals were 
purchased from Sigma Chemical Co. Ltd. (St. Louis, MO, USA.). 
PBMC isolation and culture  
Human PBMC were isolated from heparinized venous blood of healthy volunteers using a 
gradient of Lymphoprep (AXIX-SHIELD, Oslo, Norway) according to the manufacturer’s protocol 
as previously described [26].  Briefly, the gradient was centrifuged at 800 X g and the PBMC at 
the interface were removed, washed twice and resuspended in RPMI medium-1640 (Sigma) 
containing 10 % heat-inactivated fetal bovine serum (FBS) and 100 IU/ml penicillin and 100 μg/ml 
streptomycin at 37 °C in a humidified atmosphere of 5 % CO2 in air.  PBMC were plated at 5 X 
105 / ml in 6-well plates and stimulated with GM-CSF (R&D system, Minneapolis, MN, USA) at 
various concentrations. After 4 hr, cells were collected and centrifuged.  After centrifugation, 
spent media were collected and cells were lysed and RNA was extracted.   The effect of GM-CSF 
on versican mRNA expression in PBMC was analyzed by quantitative real-time RT-PCR. 
Cytokine measurements by ELISA 
Interleukin-6 (IL-6) and monocyte chemoattractant protein-1 (MCP-1) in spent culture 
media were muasured using a sandwich enzyme-linked immunoabsorbant assay (ELISA) kit 
(BioSource, Camarillo, CA, USA) according to the manufacturer’s protocol.   Briefly, the wells 
were incubated sequentially with spent culture media, biotinylated antibody for IL-6 and MCP-1, 
and horseradish peroxidase-conjugated avidin before color development.   Standard curves were 
obtained with recombinant human IL-6 and MCP-1.   The culture medium from wells containing 
various concentration of GM-CSF was compared with that from unstimulated control (n=3, 
respectively). 
Statistical analysis 
Data were expressed as mean ± SE for the infarcted heart analysis and as mean ± SD for PBMC 
analysis.   Statistical analysis of differences of real-time RT-PCR analysis was performed by 
analysis of variance (ANOVA) with Bonferroni’s multiple-comparison correction and by the 
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unpaired t-test for PBMC analysis.   A value of P<0.05 was considered statistically significant. 
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RESULTS 
Versican expression in the infarcted heart 
To examine which splicing variants of versican are present after MI in rats, we performed 
versican splicing variant expression analysis by semi-quantitative RT-PCR with primers specific 
for each isoform.   The semi-quantitative RT-PCR results demonstrated that the V0 and V1 
isoforms of versican mRNA were expressed in rat MI, while V2 mRNA was not detected and V3 
mRNA was only faintly detected (Fig. 1A).  Sham-operated hearts did not show any detectable 
versican mRNA expression with the employed numbers of cycles of amplification for 
semi-quantification (26 cycles for V0 and 28 cycles for other isoforms) (Fig. 1B).   However, 
when PCR was performed at 40 cycles, all the splicing variants were observed using the same 
template (Fig. 1C).  In contrast, mRNA obtained from rat brain showed all of the splicing variants 
with the employed numbers of cycles of amplification for semi-quantification (Fig. 1D).   
Northern blot analysis also demonstrated that the V1 isoform was the predominantly expressed 
isoform in the infarcted heart (Fig. 2).   
Quantitative RT-PCR analysis 
To examine the changes in the level of versican mRNA after MI in rats, we performed 
quantitative RT-PCR analysis.  Figure 3A shows the time-dependent changes in versican mRNA 
expression levels.  When the level of versican mRNA expression was standardized relative to that 
of GAPDH mRNA, the relative versican mRNA expression levels in the infarcted heart at 3, 6, 12, 
and 24 hours and 2, 7, 14, and 28 days were 9.27, 26.06, 46.96, 47.93, 75.94, 49.62, 23.52 and 
15.16, respectively (Fig. 3A).  ANOVA showed that the changes of versican expression were 
significant.  On the other hand, the relative decorin mRNA expression ratios in the infarcted heart 
at 2 days, 7 days, 14 days, and 28 days were 4.55-, 4.89-, 7.84- and 18.2-fold higher, respectively, 
than those on day 1 (Fig. 3B).  The expression level of versican mRNA reached its peak 2 days 
after MI and gradually decreased through 28 days, while the expression level of decorin mRNA 
increased gradually until 28 days.   
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In situ hybridization 
Since the level of expression of versican mRNA in the infarcted heart reached its peak on 
day 2, we then assessed the localization of versican mRNA in the infarcted heart on day 2.   
Intense signals for versican mRNA were observed around the infarct zone on day 2 (Fig. 4A and 
4C).  The infiltrating cells were also positive for CD68 staining, as shown by using contiguous 
sections (indicated by arrows in Fig. 4D).  Three series of experiments with different rats showed 
the identical signal distribution pattern.  In contrast, signals for α1 (III) collagen were observed in 
spindle-shaped cells (indicated by arrows in Fig. 4F), but not in monocytes (Fig. 4E).  The results 
of hematoxylin-eosin and azan-mallory staining accorded well with the findings of Fishbein et al. 
[27].   
Ischemia/reperfusion accelerated the induction of versican mRNA expression in heart 
Since versican mRNA was expressed by CD68-positive cells (i.e., monocytes/macrophages), 
we then examined whether I/R altered the expression levels of versican mRNA.   I/R is known to 
enhance inflammatory responses such as IL-6 production from mononuclear cells [28-29].   As 
shown in Figure 5, I/R enhance the expression level of versican mRNA approximately 43-fold 
compared to that in the permanent ligation group (n=4, respectively).       
Induction of versican mRNA expression in human PBMC by GM-CSF 
Because the expression of versican mRNA was enhanced by I/R, which is characterized by 
enhancement of the inflammatory reaction, and CD68-positive cells were shown to express 
versican mRNA, we then examined whether the expression of versican mRNA was related to 
monocyte-to-macrophage differentiation, which is one of the important events in inflammatory 
reactions.  PBMC were stimulated with GM-CSF at various concentrations for 4 hours.  The 
expression level of versican mRNA was dose-dependently increased by GM-CSF stimulation (Fig. 
6).  The induction of versican mRNA expression by GM-CSF occurred transiently during the 
differentiation of monocytes to macrophages (data not shown). 
GM-CSF induced cytokine production in human PBMC 
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   To test that GM-CSF induced inflammatory cytokine release in PBMC, we finally 
examined the production of inflammatory cytokines, IL-6 and MCP-1, in GM-CSF-stimulated 
PBMC by ELISA.  GM-CSF induced both IL-6 and MCP-1 in PBMC in a dose-dependent 
manner (Fig. 7A and 7B).  However, stimulation of PBMC with human recombinant IL-6 (50 
ng/ml) did not induce versican mRNA expression (data not shown).  
Toeda et al, Versican expression in myocardial infarction 
 
12
DISCUSSION 
   In this study, we demonstrated that versican was transiently expressed in the infarcted heart, 
and showed that infiltrating monocytes were a source of versican mRNA. Stimulation of 
monocytes with GM-CSF was shown to induce versican mRNA expression. 
   Versican has been reported to show a wide distribution in adult tissues, including the heart, 
where it has functions in pathological conditions of the vessels such as atherosclerosis and vascular 
injury [20-23-30].  Versican mRNA was transiently induced after coronary artery ligation, while 
the mRNA of decorin, one of the major PGs in the infarcted heart, was gradually increased during 
the healing process after MI (e.g., 14-28 days after coronary artery ligation), which is in line with 
previous reports, and similar to the findings for another PG, biglycan [25-31-32].   The mRNA of 
another multifunctional PG, syndecan, was reported to increase on day 2 and to reach its peak on 
day 3 in rats [33], and was thus induced slightly later than versican mRNA.   In the infarcted 
heart after 2 days of artery ligation, inflammatory response in the area surrounding the infarct 
tissues was observed [27].   Together with these data, our results demonstrated that the induction 
of versican mRNA expression precedes the induction of other PGs (i.e., syndecan, biglycan and 
decorin) and collagens, which are major components of the ECM in the infarcted heart.   The 
time-course of versican induction indicated that versican plays a characteristic role that may be 
different from that of other matrix proteins in the healing process after MI.  
Our in situ hybridization analysis using the V0/V1-specific probe demonstrated that 
monocytes/macrophages are the source of versican mRNA in the infarcted heart 2 days after artery 
ligation.  Previous reports revealed that versican was inducible in various cells, including vascular 
smooth muscle cells and endothelial cells under stimulation with growth factors [20-34].  The 
significance of the V0/V1 splicing form in the infarcted heart will be investigated in future studies.   
Recently, THP-1 cells, which are a human leukemic monocytic cell line, were reported to express 
versican mRNA [35].  Our results are in line with that report, and demonstrated, in addition, that 
infiltrating monocytes/macrophages express versican in an in vivo tissue injury model.   The 
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differentiation of monocytes to macrophages is another important factor in inflammation [36].   
Monocyte-to-macrophage differentiation is associated with collagen deposition in the healing heart 
after infarction.   Recently, Frangogiannis et al. reported that mature macrophages are found in an 
area of collagen deposition in the infarct area [37].  Because versican expression was shown to 
precede collagen expression, as we reported previously [2], the fact that monocytes express 
versican may indicate that versican is involved in monocyte-to-macrophage differentiation in the 
infarcted heart.   
Ischemia/reperfusion induced versican mRNA expression.   The importance of 
inflammation in myocardial infarction has been recognized [38].  The infiltrating cells including 
monocytes play roles in the cardiac repair process through a complex cascade involving cytokines 
and growth factors [38].  Monocytes/macrophages create an environment rich in inflammatory 
cells, capable of regulating extracellular matrix metabolism as well as cell proliferation through the 
production of a variety of cytokines and growth factors.  Wight et al. reported that 
versican-HA-enriched matrix may influence the retention of inflammatory cells [34].   Although 
our findings do not primarily deal with the direct biological function of versican in I/R, the 
induction of versican by I/R was in accord with the increased inflammatory reaction in the 
ischemic-reperfused myocardium.  Taking into account the previous findings as well as our result, 
it can be postulated that versican-expressing monocytes contribute to increasing the extracellular 
matrix environment under inflammatory conditions, along with fibroblasts, which are known to 
secrete HA.       
GM-CSF is a cytokine that stimulates the growth and differentiation of granulocyte and 
macrophage precursor cells [10].  GM-CSF was reported to increase the infiltration of 
monocyte-derived macrophages in the infarcted heart [11].  GM-CSF was also reported to 
increase after MI and to be related to LV dysfunction after MI [39], although Woldbaek et al. 
reported that the mRNA of GM-CSF was not detected in the infarcted heart in mice [40].  These 
data indicate that GM-CSF is produced in other organs and circulates throughout the body, 
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including the healing infarcted heart.  Many studies have demonstrated that GM-CSF promotes 
the infiltration of monocytes and macrophages after tissue injury.   However, GM-CSF itself has 
no effect on monocyte transmigration or adhesion [41].  Under certain conditions in which 
chemoattractants such as MCP-1 are produced in response to injury, GM-CSF promotes the 
effective recruitment of monocytes to local inflammatory areas [42-43].  GM-CSF was reported to 
activate Akt and extracellular signal-regulated kinase (ERK) in lipopolysaccharide 
(LPS)-stimulated lung, and nuclear factor-kappaB (NFκB) and activator protein-1 (AP-1) were 
involved in this effect in the LPS-stimulated lung [44].  Versican is known to be induced by 
platelet-derived growth factor (PDGF) in smooth muscle cells and ERK was reported to be 
involved in this induction [45].  Thus, a similar cellular mechanism is proposed in our system, but 
this possibility remains to be tested.     
One limitation of this study is that the biological function of versican expressed by 
monocyte/macrophages in the infarcted heart is obscure.  One of the complexities of clarifying its 
biological function is due to the existence of isoforms of versican but, from a different point of 
view, isoforms may be interesting alternative tools.  Versican has four isoforms and Cattaruzza et 
al. reported that angiogenic endothelial cells produce de novo the V3 isoform (which lacks the 
large size and high charge density of other isoforms, but retains the HA-binding domain of the 
larger isoforms), which could not be identified with the probe used for Northern analysis in the 
present study [20].  Recently, Lemire et al. reported that treatment with the V3 isoform affects the 
cell functions of arterial smooth muscle [46].  From the therapeutic standpoint, those findings may 
be useful information.     
In conclusion, the present study demonstrated the transient induction of versican in the 
infarcted heart, indicating that versican may contribute to the inflammatory reaction and/or 
differentiation of monocytes in the infarct area.   This is the first report showing that infiltrating 
cells express an extracellular matrix gene in the inflammatory phase after infarction, which may be 
associated with subsequent chemotaxis in the infarcted heart.  
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Table I.  The primers used for the quantitative real-time RT-PCR analysis.   
    
versican for real-time PCR Forward 5'-TGGTTGTAAATGGTCATCC-3' 
    
  Reverse  5'-CCATCTTCATCTTCCTCACT-3'  
    
versican V0  Forward 5'-GATCACGAGTATCACATGAC-3' 
    
  Reverse  5'-CAGTGATGTACTGCACTGAC-3' 
    
versican V1  Forward 5'-GCTTTGACCAGTGCGATTAC-3' 
    
  Reverse  5'-CAGTGATGTACTGCACTGAC-3' 
    
versican V2  Forward 5'-GATCACGAGTATCACATGAC-3' 
    
  Reverse  5'-AGAGGCATCTAAATGTATTCAG-3'
    
versican V3  Forward 5'-GCTTTGACCAGTGCGATTAC-3' 
    
  Reverse  5'-AGAGGCATCTAAATGTATTCAG-3'
    
GAPDH   Forward 5’-AACACAGTCCATGCCATCAC-3’ 
    
  Reverse 5’-TCCACCACCCTGTTGCTGTA-3’  
    
decorin  Forward 5’-TGGACTGAACCGTATGATTG-3’ 
    
    Reverse 5’-GCTGGCTGCATCAACTTT-3’  
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Figure legends 
Figure 1.  Splicing variant analysis of versican mRNA in myocardial infarction.  Splicing 
variant-specific primers (for V0, V1, V2 and V3, respectively) were used for RT-PCR analysis.   
An equal amount of template was used for each RT-PCR analysis.  A molecular size marker, 100 
bp ladder, was loaded in the light lane in each panel.    A. Infarcted heart expressed versican V0 
and V1 forms after artery ligation, while V2 mRNA was not detected and V3 mRNA was only 
faintly detected.   B. Sham-operated heart showed undetectable expression of versican mRNA at 
the same number of cycles of RT-PCR as used in A.   C. The same templates as used in B were 
used for 40 cycles in RT- PCR analysis.  Note that sham-operated heart expressed all the splicing 
variants at low levels.   D. Brain cDNA was used as a control for all splicing variant forms. 
Figure 2.  Representative results of Northern blot analysis in the infarcted heart.   Northern 
blot analysis revealed the transient induction of versican mRNA in rat infarction (cont, normal 
heart; 2 d, 2 days after artery ligation; 7 d, 7 days after artery ligation; 14 d, 14 days after artery 
ligation; 28 d, 28 days after artery ligation).  The hybridized band corresponded to the V1 isoform, 
as indicated by its size.  Note that versican mRNA expression was upregulated 2 days after artery 
ligation, and then decreased.   
Figure 3. A: Quantitative real-time RT-PCR analysis of versican mRNA in the infarcted 
heart.   3 hr, 3 hours after artery ligation; 6 hr, 6 hours after artery ligation; 12 hr, 12 hours after 
artery ligation; 1 d, 1 day after artery ligation; 2 d, 2 days after artery ligation; 1 d, 1 day after 
artery ligation; 7 d, 7 days after artery ligation; 14 d, 14 days after artery ligation; 28 d, 28 days 
after artery ligation (n=6, mean ± SE).  Closed circles indicate infarcted heart and open-circles 
indicate sham-operated heart.   Note that the relative versican mRNA level (the ratio of the 
expression level of versican/GAPDH mRNA) was increased as early as 6 hours, and the transient 
induction of versican reached its peak at 2 days after coronary artery ligation.   * Indicates P 
<0.05 compared to compared to 3 hr.   Sequential changes in versican mRNA expression are also 
noted.   B:  Quantitative real-time RT-PCR analysis of decorin mRNA in the infarcted 
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heart.  In the infarct zone, decorin reached its peak 28 days after ligation, exhibiting a pattern of 
gradual increase different from that of versican mRNA (n=6, mean ± SE).  The expression level 
of decorin mRNA is shown as fold-increase compared with that 1 day after ligation.   All the 
quantitative real-time PCR analyses were repeated three times.    
Figure 4.  In situ hybridization analysis of versican mRNA in the infarcted heart.   
Versican mRNA signals were observed in the infarct peripheral zone.   ‘MI-center’ indicates the 
infarct central zone.  A: Versican mRNA detected in the infarct peripheral zone 2 days after MI.  
The boxed area shows the area observed at higher magnification in C.  B: Hybridization with 
sense-probe in the infarcted heart 2 days after MI.  There were no signals detected.   The boxed 
area shows the area observed at higher magnification in E.  C: Higher magnification of the boxed 
region in A.   Versican mRNA was detected in the mononuclear cells (blue) in the area 
surrounding the infarct zone 2 days after MI.   D: CD68 immunostaining observed in a 
contiguous section is shown for comparison.   Numerous infiltrating monocytes were observed in 
the area surrounding the infarct zone 2 days after MI (brown).   Note that versican mRNA was 
detected in CD68-positive cells (arrows), as shown in C.   E: Higher magnification of the boxed 
region in B (with sense-probe).  F: α1 (III) mRNA expression (blue) in the infarcted heart 
(contiguous sections to 3E).  There was no detectable α1 (III) mRNA expression in the presumed 
monocytes (arrows) using contiguous sections.   Spindle-shaped mesenchymal cells (presumably 
fibroblasts) expressed α1 (III) mRNA.  Note that the distribution pattern of versican mRNA was 
distinct from that of collagen mRNA.   A scale bar is shown in each panel.    
Figure 5.  Enhancement of versican mRNA induction by reperfusion in the infarcted heart.   
RNA was extracted from the permanent ligation group (permanent) and ischemia/reperfusion (I/R) 
group (n=4, respectively).  The amount of versican mRNA was determined by real-time RT-PCR 
analysis and compared with that in the permanent ligation group as fold-increase.  
Ischemia/reperfusion significantly induced versican mRNA (43.35±23.75) in the infarcted heart 
(mean ± SE).  * Indicates P <0.01 compared to the permanent ligation group.   
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Figure 6.  Effect of GM-CSF on versican mRNA expression in PBMC.  PBMC were 
stimulated with various concentrations of GM-CSF for 4 hr.  The levels of versican mRNA 
expression were normalized with that of GAPDH and compared with the levels in unstimulated 
cells and expressed as fold-increase.   The expression level of versican mRNA was 
dose-dependently increased (n=3, mean ± SD).  * Indicates P <0.05 compared to unstimulated 
cells. 
 
Figure 7.  GM-CSF induced IL-6 and TNFα production in PBMC.  Human PBMC were 
isolated as described in Material and Methods.  PBMC were stimulated with various 
concentrations of GM-CSF for 4 hr.  The induction of IlL-6 and MCP-1 were measured by ELISA.   
The induction of cytokines was dose-dependently increased (n=3, mean ± SD).  * Indicates P 
<0.05 compared to unstimulated cells. 
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